Brief: Coya Therapeutics, Inc. Provides Business Update And Reports FY 2022 Unaudited Financial Results
29/03/2023 21:34
March 29 (Reuters) - Coya Therapeutics Inc COYA.O :
* COYA THERAPEUTICS, INC. PROVIDES BUSINESS UPDATE AND
REPORTS FY
2022 UNAUDITED FINANCIAL RESULTS
* COYA THERAPEUTICS INC- AS OF DECEMBER 31, 2022, COYA HAD
CASH
AND CASH EQUIVALENTS OF $5.9 MILLION COMPARED TO $4.3 MILLION AS
OF DECEMBER 31, 2021
Source text for Eikon: ID:nBwbbGZrFa
Further company coverage: COYA.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Coya Therapeutics
See all newsCoya Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Coya Therapeutics Q2 net loss widens as R&D costs rise
Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Coya Therapeutics Entered Into Sales Agreement, May Offer And Sell From Time To Time Shares Of Co's Common Stock For Up To $30 Million
Brief: Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation For Coya 302 For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)